Anesthesia: Hospital And Specialty Cycle Quiz!
(133).jpg "Anesthesia: Hospital And Specialty Cycle Quiz! - Quiz")
Hospital and speciality cycle quiz! Different drugs are expected to reach a certain way once introduced to the body and if they don’t a medical practitioner is expected to find out the reason for the difference and what to do to get desired results on a patient. How conversant are you when it comes to anaesthetic drugs or techniques? These questions will help refresh your memory. Give them a shot!
- 1.
Following are true for Rocuronium Bromide, Except.
- A.
Indicated as adjunct to general anesthesia to facilitate routine Endotracheal Intubation to provide skeletal muscle relaxation during surgery or mechanical ventilation
- B.
Indicated as adjunct to general anesthesia to facilitate Rapid Sequence Intubation to provide skeletal muscle relaxation during surgery or mechanical ventilation
- C.
Rocuronium bromide is a nondepolarizing neuromuscular blocking agent with rapid to intermediate onset and an intermediate duration of action, depending on dose used
- D.
Rocuronium has its effect on Conciousness, pain threshold, thinking ability and memory.
- E.
Route of administration is Intravenous.
Correct Answer
D. Rocuronium has its effect on Conciousness, pain threshold, thinking ability and memory.Explanation
Rocuronium bromide has its effect on consciousness, pain threshold, thinking ability, and memory. This statement is incorrect because Rocuronium bromide is a neuromuscular blocking agent and its main effect is on skeletal muscle relaxation during surgery or mechanical ventilation. It does not have any direct effect on consciousness, pain threshold, thinking ability, or memory.Rate this question:
-
- 2.
Succinylcholine belongs to which of the following groups of Neuromuscular Blocking Agent.
- A.
Aminosteroid NMBA
- B.
Benzyllisoquinolines NMBA
- C.
Depolarizing NMBA
- D.
Non-Depolarizing NMBA
Correct Answer
C. Depolarizing NMBAExplanation
Succinylcholine is classified as a depolarizing neuromuscular blocking agent. Depolarizing NMBA's work by initially causing depolarization of the motor end plate, which leads to muscle fasciculation. This is followed by a prolonged depolarization phase, during which the muscle remains in a state of paralysis. This medication is commonly used for rapid sequence intubation and short surgical procedures. It is important to note that succinylcholine has a relatively short duration of action compared to non-depolarizing NMBA's, making it a preferred choice in certain clinical situations.Rate this question:
-
- 3.
The best explanation for Anesthesia is...
- A.
Irreversible Loss of Feeling or Sensation in all parts of body
- B.
Reversible Loss of Feeling or Sensation in part of body
- C.
Reversible Loss of Feeling or Sensation in All or Part of Body
- D.
All or Above
Correct Answer
C. Reversible Loss of Feeling or Sensation in All or Part of BodyExplanation
Anesthesia refers to the reversible loss of feeling or sensation in all or part of the body. This means that the person who undergoes anesthesia will not feel pain or have any sensation in the areas where the anesthesia is administered. It is important to note that anesthesia can be administered either locally, affecting only a specific part of the body, or generally, affecting the entire body. Therefore, the correct answer is "Reversible Loss of Feeling or Sensation in All or Part of Body."Rate this question:
-
- 4.
Types of Anesthesia.
- A.
General Anesthesia
- B.
Local Anesthesia
- C.
Regional Anestehsia
- D.
Spinal or Epidural Anesthesia
- E.
All of Above
Correct Answer
E. All of AboveExplanation
The correct answer is "All of Above" because it includes all the types of anesthesia mentioned in the given options. General anesthesia refers to the complete loss of consciousness during a medical procedure, local anesthesia involves numbing a specific area of the body, regional anesthesia blocks pain in a larger area of the body, and spinal or epidural anesthesia is used for procedures involving the lower part of the body. Therefore, "All of Above" encompasses all the different types of anesthesia listed.Rate this question:
-
- 5.
Following are the routes of Anesthesia, Except
- A.
Intravenous Anesthesia
- B.
Inhalation Anesthesia
- C.
Oral Anesthesia
- D.
Total Intravenous Anesthesia
- E.
Non of Above
Correct Answer
C. Oral AnesthesiaExplanation
The given correct answer is "Oral Anesthesia." This is because oral anesthesia is not a recognized route of administering anesthesia. Anesthesia can be delivered intravenously, through inhalation, or via total intravenous anesthesia, but not orally.Rate this question:
-
- 6.
The Triad of Anesthesia include following, Except
- A.
Analgesia
- B.
Sleep / Hypnosis
- C.
Muscle Relaxation
- D.
Memory Loss
- E.
Non of Above
Correct Answer
D. Memory LossExplanation
The Triad of Anesthesia consists of three components: analgesia (pain relief), sleep/hypnosis (inducing a state of unconsciousness), and muscle relaxation. Memory loss is not a part of the Triad of Anesthesia. This means that memory loss is not one of the essential components required for achieving a state of anesthesia.Rate this question:
-
- 7.
According to American Society of Anesthesiologists, ASA-3 assign for the physical status who are;
- A.
Patients with Mild Systemic Disease
- B.
Normal Healthy Person with no significant illness or disability
- C.
Patients with Severe uncontrolled medical problems that are life threatening
- D.
Patients with severe systemic disease that effect their daily life but not life threatening
- E.
A brain dead person being taken for Organ donation surgery
Correct Answer
D. Patients with severe systemic disease that effect their daily life but not life threateningExplanation
ASA-3 is assigned to patients with severe systemic disease that affects their daily life but is not life-threatening. This means that these patients have significant medical issues that impact their ability to carry out their daily activities, but their condition is not immediately life-threatening. In the given scenario, a brain dead person being taken for organ donation surgery would fall under this category as they have a severe systemic disease (brain death) that does not pose an immediate threat to their life.Rate this question:
-
- 8.
Acetylcholine is one of the most important Neurotransmitters, made up of Acetyl Co-A and Choline Molecules. Which of the following is it's the site of release, at Neuromuscular junction?
- A.
Presynaptic Neuromuscular Vasicles
- B.
Post-synaptic Nicotinic receptor sites
- C.
Inter-synaptic Membrane
- D.
I dont know
- E.
All of Above
Correct Answer
A. Presynaptic Neuromuscular VasiclesExplanation
Acetylcholine is released from the presynaptic neuromuscular vesicles at the neuromuscular junction. This is where the nerve terminal and the muscle fiber meet, and acetylcholine is released into the synaptic cleft to bind to the post-synaptic nicotinic receptor sites on the muscle fiber. The inter-synaptic membrane refers to the membrane between two synapses and is not the site of release for acetylcholine. The answer "I don't know" is not correct. Therefore, the correct answer is Presynaptic Neuromuscular Vesicles.Rate this question:
-
- 9.
Total clinical Duration...
- A.
Time (min) from end of injection till recovery of neuromuscular transmission (twitch height) to a level of 90% of control
- B.
Time between start of injection and the first moment at which endotracheal intubation can be performed
- C.
Time between end of injection and first mooment at which endotracheal intubation can be preformed
- D.
Time (min) from start of injection till recovery of neuromuscular transmission (twitch height) to a level of 90% of control
- E.
I dont Know
- F.
Non of above
Correct Answer
A. Time (min) from end of injection till recovery of neuromuscular transmission (twitch height) to a level of 90% of controlExplanation
The correct answer is "Time (min) from end of injection till recovery of neuromuscular transmission (twitch height) to a level of 90% of control." This answer refers to the duration of time it takes for the neuromuscular transmission to recover to 90% of its original strength after the injection has been administered. This is an important measure in clinical settings as it helps determine the effectiveness and duration of the medication or treatment being used.Rate this question:
-
- 10.
PACU means
Correct Answer
Post anesthesia care unitExplanation
PACU stands for Post Anesthesia Care Unit, which is a specialized area in a hospital where patients are closely monitored after undergoing anesthesia. In the PACU, patients are observed for any complications or side effects that may arise from the anesthesia, such as respiratory issues, pain management, and recovery from the effects of anesthesia. The PACU staff ensures that patients are stable and ready to be transferred to a regular hospital room or discharged home.Rate this question:
- 11.
Which of the following are the Strengths of Cis-atracurium, Except
- A.
Organ-independent elimination (less prolonged recovery in elderly and renal/hepatic impaired)
- B.
No significant histamine release
- C.
Slow onset
- D.
Suitable for CV-unstable and atopic patients
- E.
Ready to Use
- F.
Non of Above
Correct Answer
C. Slow onsetExplanation
Cis-atracurium has several strengths, including organ-independent elimination, no significant histamine release, suitability for CV-unstable and atopic patients, and being ready to use. However, the one strength that it does not possess is a slow onset.Rate this question:
-
- 12.
Regarding Suxamethonium (Anectin)
- A.
Ultra short duration of Action
- B.
Short Recovery
- C.
Low Cost
- D.
Can be fully reversed spontaneously
- E.
Ideal for Rapid sequence intubation despite of inavailability of reversal
- F.
Suitable for short procedures
- G.
Incidence of having higer Intragastric, Intracranial and Intraocular Pressure
- H.
Belongs to Non-Depolarizing neuromuscular blocking agents family
- I.
Suitable for patients with severe burns, muscular dystrophies, and hyperkalemia
- J.
Suitable for patients with renal or hepatic failure
Correct Answer(s)
A. Ultra short duration of Action
B. Short Recovery
C. Low Cost
E. Ideal for Rapid sequence intubation despite of inavailability of reversal
F. Suitable for short procedures
G. Incidence of having higer Intragastric, Intracranial and Intraocular PressureExplanation
Suxamethonium (Anectin) is a drug that has an ultra short duration of action, meaning it quickly wears off after administration. It also has a short recovery time, allowing patients to regain their muscle function relatively quickly. Additionally, it is a low-cost option, making it more accessible for medical professionals. It can be used for rapid sequence intubation even if a reversal agent is not available. It is suitable for short procedures and is commonly used in situations where there is a need for rapid muscle relaxation. However, it is important to note that it can increase intragastric, intracranial, and intraocular pressure, which may not be suitable for all patients. It belongs to the non-depolarizing neuromuscular blocking agents family and is particularly beneficial for patients with severe burns, muscular dystrophies, and hyperkalemia, as well as those with renal or hepatic failure.Rate this question:
-
- 13.
Regarding Atracurium
- A.
Belongs to Non-Depolarizing Neuromuscular blocker family
- B.
Having Organ-independent elimination (less prolonged recovery in elderly and renal/hepatic impaired)
- C.
No significant Histamine release
- D.
Stable in Vial
- E.
Relatively Higher cost
- F.
Produces Laudanosine, as a by product on long term usage
- G.
Can be fully reversed from Deep and Intense Block with the Traditional reversing agent
- H.
Highly predictable on Intubation time and Clinical Duration
- I.
May cause increased heart rate and fall in blood pressure
Correct Answer(s)
A. Belongs to Non-Depolarizing Neuromuscular blocker family
B. Having Organ-independent elimination (less prolonged recovery in elderly and renal/hepatic impaired)
F. Produces Laudanosine, as a by product on long term usage
I. May cause increased heart rate and fall in blood pressureExplanation
Atracurium belongs to the Non-Depolarizing Neuromuscular blocker family, which means it works by blocking the action of acetylcholine at the neuromuscular junction, resulting in muscle relaxation. It has organ-independent elimination, meaning its effects are not significantly prolonged in elderly or patients with renal or hepatic impairment. Atracurium produces a byproduct called Laudanosine when used for a long time. It may cause an increased heart rate and a fall in blood pressure as side effects.Rate this question:
-
- 14.
Select True options from the below statements:
- A.
Rocuronium is fully reversable from any depth of block with the use of Sugammadex
- B.
Sugammadex works with any type of Neuromuscular Blocker
- C.
Sugammadex and Cisatracurium is the one of the ideal choices for Laproscopic Surgeries
- D.
Sugammadex is modified cyclodextrin and not new to our human body
- E.
There are many Specific Reversle agents for neuromuscular block available in the market
- F.
Sugammdex can be a life saver in Cannot Intubate, Cannot Ventilate Situations
- G.
Route of administration for Sugammadex is Intra Muscular
- H.
Rocuronium in Normal doses can effect the normal Cardio pulmonary fuctions
Correct Answer(s)
A. Rocuronium is fully reversable from any depth of block with the use of Sugammadex
D. Sugammadex is modified cyclodextrin and not new to our human body
F. Sugammdex can be a life saver in Cannot Intubate, Cannot Ventilate SituationsExplanation
Rocuronium is fully reversible from any depth of block with the use of Sugammadex. This means that Sugammadex can effectively reverse the effects of Rocuronium, regardless of the level of muscle relaxation.
Sugammadex is a modified cyclodextrin and not new to our human body. This indicates that Sugammadex is a known substance in the human body and has been modified to have specific properties for reversing neuromuscular blockade.
Sugammadex can be a life saver in Cannot Intubate, Cannot Ventilate (CICV) situations. This suggests that Sugammadex can be crucial in emergency situations where a patient cannot be intubated or ventilated, providing a potential life-saving solution.Rate this question:
-
- 15.
Regarding Rocuronium
- A.
Also known as Zemuron®, Eslax® and rocuronium
- B.
Fast onset, intermediate-acting aminosteroid NMBA
- C.
Binds nicotinic receptors at the neuromuscular junction – like ACh
- D.
Flexible dosing - Not suitable for Short, intermediate and long procedures
- E.
Good cardiovascular safety
- F.
Suitable for a wide variety of patient and clinical settings
- G.
Indicated In intensive care unit (ICU) To facilitate intubation and mechanical ventilation
- H.
Does not significantly increase plasma histamine levels
- I.
Possible prolongation of action in patients with clinically significant liver disease or renal failure
- J.
In obese Patients Dose should be based on estimated Actual body weight
- K.
Highly Inpredictable
Correct Answer(s)
A. Also known as Zemuron®, Eslax® and rocuronium
B. Fast onset, intermediate-acting aminosteroid NMBA
C. Binds nicotinic receptors at the neuromuscular junction – like ACh
E. Good cardiovascular safety
G. Indicated In intensive care unit (ICU) To facilitate intubation and mechanical ventilation
H. Does not significantly increase plasma histamine levels
I. Possible prolongation of action in patients with clinically significant liver disease or renal failureExplanation
Rocuronium, also known as Zemuron®, Eslax®, and rocuronium, is a fast onset, intermediate-acting aminosteroid NMBA. It binds to nicotinic receptors at the neuromuscular junction, similar to acetylcholine (ACh). It has good cardiovascular safety and is suitable for a wide variety of patient and clinical settings. It is indicated in the intensive care unit (ICU) to facilitate intubation and mechanical ventilation. It does not significantly increase plasma histamine levels. However, it may have a prolonged action in patients with clinically significant liver disease or renal failure. In obese patients, the dose should be based on estimated actual body weight. Overall, rocuronium is highly unpredictable.Rate this question:
-
- 16.
Regarding Rocuronium Bromide
- A.
Only rapid onset non-depolarizing NMBA – low risk of pulmonary aspiration/regurgitation and rapid intubation is possible
- B.
Organ-Independent elimination
- C.
Flexible dosing – easy to titrate
- D.
Fully Reversible
- E.
In solution – stable up to 30C for 3 months
- F.
No active metabolites
- G.
Indicated for RSI
- H.
Has significant effect on Heart Rate and Blood Pressure
- I.
Has Effects on APGAR score, of New born
- J.
Relatively Expensive, in comparison to Suxamethonium
Correct Answer(s)
A. Only rapid onset non-depolarizing NMBA – low risk of pulmonary aspiration/regurgitation and rapid intubation is possible
C. Flexible dosing – easy to titrate
D. Fully Reversible
E. In solution – stable up to 30C for 3 months
F. No active metabolites
G. Indicated for RSI
J. Relatively Expensive, in comparison to SuxamethoniumExplanation
Rocuronium Bromide is the only rapid onset non-depolarizing NMBA, meaning it quickly induces muscle relaxation for intubation. It has a low risk of causing pulmonary aspiration or regurgitation during intubation. It can be easily titrated with flexible dosing, allowing for precise control of muscle relaxation. It is fully reversible, meaning its effects can be quickly reversed if needed. It is stable in solution at temperatures up to 30 degrees Celsius for three months. It does not have any active metabolites. It is indicated for rapid sequence intubation (RSI). However, it is relatively expensive compared to Suxamethonium, another muscle relaxant.Rate this question:
-
- 17.
Regarding Rocuronium in Pediatric Population:
- A.
For infants (28 days-23 months), children (2-11 years) and adolescents (12- 18 years) the recommended intubation dose during routine anesthesia and maintenance dose are similar to those in adults.
- B.
For continuous infusion in pediatrics, the infusion rates, with exception of children, are the same as for adults
- C.
There are insufficient data to support dose recommendations for the use of rocuronium bromide in neonates (0-1 month).
- D.
The experience with rocuronium bromide in rapid sequence induction in pediatric patients is limited. Rocuronium bromide is therefore not recommended for facilitating tracheal intubation conditions during rapid sequence induction in pediatric patients.
Correct Answer(s)
A. For infants (28 days-23 months), children (2-11 years) and adolescents (12- 18 years) the recommended intubation dose during routine anesthesia and maintenance dose are similar to those in adults.
B. For continuous infusion in pediatrics, the infusion rates, with exception of children, are the same as for adults
C. There are insufficient data to support dose recommendations for the use of rocuronium bromide in neonates (0-1 month).
D. The experience with rocuronium bromide in rapid sequence induction in pediatric patients is limited. Rocuronium bromide is therefore not recommended for facilitating tracheal intubation conditions during rapid sequence induction in pediatric patients.Explanation
The given answer states that the recommended intubation dose and maintenance dose of Rocuronium in infants, children, and adolescents are similar to those in adults. It also mentions that the infusion rates for continuous infusion in pediatrics, except for children, are the same as for adults. However, there is insufficient data to support dose recommendations for the use of Rocuronium in neonates. Additionally, the experience with Rocuronium in rapid sequence induction in pediatric patients is limited, so it is not recommended for facilitating tracheal intubation conditions during rapid sequence induction in pediatric patients.Rate this question:
-
- 18.
The Use of Rocuronium in Hepatic and Renal Insufficiency:
- A.
The standard intubation dose for geriatric patients and patients with hepatic and/or biliary tract disease and/or renal failure during routine anesthesia is 0.6 mg.kg-1 rocuronium bromide
- B.
A dose of 0.6 mg.kg-1 should be considered for rapid sequence induction of anesthesia in patients in which a prolonged duration of action is expected
- C.
Regardless of the anesthetic technique used, the recommended maintenance dose for these patients is 0.075-0.1 mg.kg-1 rocuronium bromide, and the recommended infusion rate is 0.3-0.4 mg.kg-1.h-1
- D.
The dose of Rocuronium should be same as of Normal healthy adult, as it will not effect the Liver enzymes and Renal function
Correct Answer(s)
A. The standard intubation dose for geriatric patients and patients with hepatic and/or biliary tract disease and/or renal failure during routine anesthesia is 0.6 mg.kg-1 rocuronium bromide
B. A dose of 0.6 mg.kg-1 should be considered for rapid sequence induction of anesthesia in patients in which a prolonged duration of action is expected
C. Regardless of the anesthetic technique used, the recommended maintenance dose for these patients is 0.075-0.1 mg.kg-1 rocuronium bromide, and the recommended infusion rate is 0.3-0.4 mg.kg-1.h-1Explanation
The recommended dose of Rocuronium for geriatric patients and patients with hepatic and/or biliary tract disease and/or renal failure during routine anesthesia is 0.6 mg.kg-1. This dose should also be considered for rapid sequence induction of anesthesia in patients where a prolonged duration of action is expected. Regardless of the anesthetic technique used, the recommended maintenance dose for these patients is 0.075-0.1 mg.kg-1, and the recommended infusion rate is 0.3-0.4 mg.kg-1.h-1. This is because the dose of Rocuronium should be the same as that for a normal healthy adult, as it does not affect liver enzymes and renal function.Rate this question:
-
- 19.
Regarding Rocuronium in Pregnancy and Cesarean section:
- A.
For rocuronium bromide, no clinical data on exposed pregnancies are available. Caution should be exercised when prescribing Esmeron to pregnant women.
- B.
In patients undergoing Cesarean section, Esmeron can be used as part of a rapid sequence induction technique, provided no intubation difficulties are anticipated and a sufficient dose of anesthetic agent is administered
- C.
Esmeron, administered in doses of 0.6 mg.kg-1, has been shown to be safe in parturients undergoing Cesarean section
- D.
Esmeron does not affect Apgar score, fetal muscle tone nor cardiorespiratory adaptation.
- E.
Only a dose of 0.6 mg.kg-1 is recommended in this patient group.
- F.
Rocuronium should be given to lactating women only when the attending physician decides that the benefits outweigh the risks.
Correct Answer(s)
A. For rocuronium bromide, no clinical data on exposed pregnancies are available. Caution should be exercised when prescribing Esmeron to pregnant women.
B. In patients undergoing Cesarean section, Esmeron can be used as part of a rapid sequence induction technique, provided no intubation difficulties are anticipated and a sufficient dose of anesthetic agent is administered
C. Esmeron, administered in doses of 0.6 mg.kg-1, has been shown to be safe in parturients undergoing Cesarean section
D. Esmeron does not affect Apgar score, fetal muscle tone nor cardiorespiratory adaptation.
E. Only a dose of 0.6 mg.kg-1 is recommended in this patient group.
F. Rocuronium should be given to lactating women only when the attending physician decides that the benefits outweigh the risks.Explanation
Rocuronium bromide is a medication used for muscle relaxation during surgery. The given answer states that there is no clinical data available on the use of rocuronium in pregnant women, so caution should be exercised when prescribing it to them. However, it can be used during a Cesarean section if there are no anticipated difficulties with intubation and an adequate dose of anesthetic agent is given. Studies have shown that a dose of 0.6 mg.kg-1 of Esmeron (rocuronium) is safe for parturients undergoing a Cesarean section and does not affect the Apgar score, fetal muscle tone, or cardiorespiratory adaptation. Lactating women should only receive rocuronium if the attending physician determines that the benefits outweigh the risks.Rate this question:
-
- 20.
Please select the true statement for Rocuronium:
- A.
The standard intubating dose during routine anesthesia is 0.6 mg.kg-1 rocuronium bromide, after which adequate intubation conditions are established within 60 seconds in nearly all patients
- B.
A dose of 1.0 mg.kg-1 of rocuronium bromide is recommended for facilitating tracheal intubation conditions during rapid sequence induction of anesthesia
- C.
If a dose of 0.6 mg.kg-1 rocuronium bromide is used for rapid sequence induction of anesthesia, it is recommended to intubate the patient 90 seconds after administration of rocuronium bromide
- D.
Higher dose of rocuronium is needed if the anesthetist is willing for the short recovery
Correct Answer(s)
A. The standard intubating dose during routine anesthesia is 0.6 mg.kg-1 rocuronium bromide, after which adequate intubation conditions are established within 60 seconds in nearly all patients
B. A dose of 1.0 mg.kg-1 of rocuronium bromide is recommended for facilitating tracheal intubation conditions during rapid sequence induction of anesthesia
C. If a dose of 0.6 mg.kg-1 rocuronium bromide is used for rapid sequence induction of anesthesia, it is recommended to intubate the patient 90 seconds after administration of rocuronium bromideExplanation
The correct answer states that the standard intubating dose during routine anesthesia is 0.6 mg.kg-1 rocuronium bromide, after which adequate intubation conditions are established within 60 seconds in nearly all patients. It also mentions that a dose of 1.0 mg.kg-1 of rocuronium bromide is recommended for facilitating tracheal intubation conditions during rapid sequence induction of anesthesia. Additionally, if a dose of 0.6 mg.kg-1 rocuronium bromide is used for rapid sequence induction of anesthesia, it is recommended to intubate the patient 90 seconds after administration of rocuronium bromide. This answer covers the correct information regarding the recommended doses and timing for intubation with rocuronium bromide.Rate this question:
-
- 21.
Select the Single best for Rocuronium:
- A.
Rocuronium launched in 1977
- B.
The experience with rocuronium bromide in rapid sequence induction in pediatric patients is limited. Rocuronium bromide is therefore not recommended for facilitating tracheal intubation conditions during rapid sequence induction in pediatric patients
- C.
In pediatric population, Rocuronium is the only option for Anesthetist
Correct Answer
B. The experience with rocuronium bromide in rapid sequence induction in pediatric patients is limited. Rocuronium bromide is therefore not recommended for facilitating tracheal intubation conditions during rapid sequence induction in pediatric patientsExplanation
The answer states that the experience with rocuronium bromide in rapid sequence induction in pediatric patients is limited, therefore it is not recommended for facilitating tracheal intubation conditions in pediatric patients. This suggests that there may be potential risks or complications associated with using rocuronium bromide in this specific situation, and it is advisable to explore other options.Rate this question:
-
- 22.
For Maintenance dose of Rocuronium, The recommended maintenance dose is 0.15 mg.kg-1 rocuronium bromide; in the case of long-term inhalational anesthesia, this should be reduced to 0.075-0.1 mg.kg-1 rocuronium bromide. The maintenance doses should best be given when twitch height has recovered to 25% of control twitch height, or when 2 to 3 responses to a train of four stimulation are present.
- A.
True
- B.
False
Correct Answer
A. TrueExplanation
The explanation for the given correct answer is that the recommended maintenance dose of Rocuronium is indeed 0.15 mg.kg-1 rocuronium bromide. However, in the case of long-term inhalational anesthesia, the dose should be reduced to 0.075-0.1 mg.kg-1 rocuronium bromide. It is also recommended to administer the maintenance doses when the twitch height has recovered to 25% of control twitch height or when 2 to 3 responses to a train of four stimulation are present. Therefore, the statement "The recommended maintenance dose is 0.15 mg.kg-1 rocuronium bromide" is true.Rate this question:
-
- 23.
For Continuous Infusion of Rocuronium, If rocuronium bromide is administered by continuous infusion, it is recommended to give a loading dose of 0.6 mg.kg-1 rocuronium bromide and, when neuromuscular block starts to recover, to start administration by infusion. The infusion rate should be adjusted to maintain twitch response at 10% of control twitch height or to maintain 1 to 2 responses to train of four stimulation. In adults under intravenous anesthesia, the infusion rate required to maintain neuromuscular block at this level ranges from 0.3-0.6 mg.kg-1.h-1, and under inhalational anesthesia the infusion rate ranges from 0.3-0.4 mg.kg-1.h-1. Continuous monitoring of neuromuscular block is recommended since infusion rate requirements vary from patient to patient and with the anesthetic method used.
- A.
True
- B.
False
Correct Answer
A. TrueExplanation
The statement is true because when administering rocuronium bromide by continuous infusion, it is recommended to give a loading dose and then start administration by infusion. The infusion rate should be adjusted to maintain the desired level of neuromuscular block. The recommended infusion rates vary depending on the type of anesthesia used. Continuous monitoring of neuromuscular block is also recommended as the infusion rate requirements can vary between patients and with different anesthetic methods.Rate this question:
-
- 24.
For Obese Patients, When used in overweight or obese patients (defined as patients with a body weight of 30% or more above ideal body weight) doses should be reduced taking into account ideal body weight.
- A.
True
- B.
False
Correct Answer
A. TrueExplanation
The explanation for the answer "True" is that in obese patients, doses of medication should be reduced based on their ideal body weight rather than their actual body weight. This is because the ideal body weight is a more accurate representation of the patient's size and metabolism, and using it to calculate the dosage can help prevent potential complications or adverse effects.Rate this question:
-
Quiz Review Timeline +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.
-
Current Version
-
Mar 21, 2023Quiz Edited by
ProProfs Editorial Team -
May 05, 2012Quiz Created by
Dr_Arsalan
- Addiction Quizzes
- AIDS Quizzes
- Allergic Quizzes
- Allergy Quizzes
- Alzheimer Quizzes
- Anemia Quizzes
- Arthritis Quizzes
- Asthma Quizzes
- Bipolar Disorder Quizzes
- Burn Quizzes
- Cancer Quizzes
- Cerebral Palsy Quizzes
- COPD Quizzes
- Dengue Quizzes
- Depression Quizzes
- Diabetes Quizzes
- Disorder Quizzes
- Gastrointestinal Disease Quizzes
- Headache Quizzes
- Hepatitis Quizzes
- Hypertension Quizzes
- Infectious Disease Quizzes
- Influenza Quizzes
- Insomnia Quizzes
- Lung Cancer Quizzes
- Lung Disease Quizzes
- Malaria Quizzes
- Neoplasia Quizzes
- Obesity Quizzes
- Osteoporosis Quizzes
- Pandemic Quizzes
- Personality Disorder Quizzes
- Pulmonology Quizzes
- Sexually Transmitted Disease Quizzes
- Sinus Quizzes
- SLE Quizzes
- Thyroid Disease Quizzes
- Viral Quizzes
Back to top